These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25530024)

  • 1. Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
    Lehto J; Hirvonen MM; Johansson J; Kemppainen J; Luoto P; Naukkarinen T; Oikonen V; Arponen E; Rouru J; Sallinen J; Scheinin H; Vuorilehto L; Finnema SJ; Halldin C; Rinne JO; Scheinin M
    Synapse; 2015 Mar; 69(3):172-81. PubMed ID: 25530024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
    Lehto J; Virta JR; Oikonen V; Roivainen A; Luoto P; Arponen E; Helin S; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Virtanen K; Volanen I; Scheinin M; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):120-7. PubMed ID: 25201008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
    Finnema SJ; Hughes ZA; Haaparanta-Solin M; Stepanov V; Nakao R; Varnäs K; Varrone A; Arponen E; Marjamäki P; Pohjanoksa K; Vuorilehto L; Babalola PA; Solin O; Grimwood S; Sallinen J; Farde L; Scheinin M; Halldin C
    Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25522417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.
    Lehto J; Scheinin A; Johansson J; Marjamäki P; Arponen E; Scheinin H; Scheinin M
    Synapse; 2016 Feb; 70(2):57-65. PubMed ID: 26562363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
    Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the PET ligand [
    Shahid M; Rinne JO; Scheinin M; Virta J; Marjamäki P; Solin O; Arponen E; Sallinen J; Kuokkanen K; Rouru J
    EJNMMI Res; 2020 Dec; 10(1):152. PubMed ID: 33296042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.
    Lehto J; Johansson J; Vuorilehto L; Luoto P; Arponen E; Scheinin H; Rouru J; Scheinin M
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4169-78. PubMed ID: 25918111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
    Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors.
    Alluri S; Eisenberg SM; Grisanti LA; Tanner M; Volkow ND; Kim SW; Kil KE
    Eur J Med Chem; 2022 Dec; 243():114764. PubMed ID: 36272201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine challenge decreases yohimbine binding to α2 adrenoceptors in Landrace pig brain.
    Landau AM; Doudet DJ; Jakobsen S
    Psychopharmacology (Berl); 2012 Jul; 222(1):155-63. PubMed ID: 22227612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and Preclinical Evaluation of an α
    Krzyczmonik A; Keller T; López-Picón FR; Forsback S; Kirjavainen AK; Takkinen JS; Wasilewska A; Scheinin M; Haaparanta-Solin M; Sączewski F; Solin O
    Mol Imaging Biol; 2019 Oct; 21(5):879-887. PubMed ID: 30710261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
    Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
    Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping α2 adrenoceptors of the human brain with 11C-yohimbine.
    Nahimi A; Jakobsen S; Munk OL; Vang K; Phan JA; Rodell A; Gjedde A
    J Nucl Med; 2015 Mar; 56(3):392-8. PubMed ID: 25635132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies.
    Shiue C; Pleus RC; Shiue GG; Rysavy JA; Sunderland JJ; Cornish KG; Young SD; Bylund DB
    Nucl Med Biol; 1998 Feb; 25(2):127-33. PubMed ID: 9468027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.
    Hostetler ED; Joshi AD; Sanabria-Bohórquez S; Fan H; Zeng Z; Purcell M; Gantert L; Riffel K; Williams M; O'Malley S; Miller P; Selnick HG; Gallicchio SN; Bell IM; Salvatore CA; Kane SA; Li CC; Hargreaves RJ; de Groot T; Bormans G; Van Hecken A; Derdelinckx I; de Hoon J; Reynders T; Declercq R; De Lepeleire I; Kennedy WP; Blanchard R; Marcantonio EE; Sur C; Cook JJ; Van Laere K; Evelhoch JL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):478-86. PubMed ID: 23975906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation.
    Bailey SR; Eid AH; Mitra S; Flavahan S; Flavahan NA
    Circ Res; 2004 May; 94(10):1367-74. PubMed ID: 15087420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different roles of alpha2-adrenoceptor subtypes in non-pregnant and late-pregnant uterine contractility in vitro in the rat.
    Gáspár R; Gál A; Gálik M; Ducza E; Minorics R; Kolarovszki-Sipiczki Z; Klukovits A; Falkay G
    Neurochem Int; 2007 Oct; 51(5):311-8. PubMed ID: 17664026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A; Billiras R; Cistarelli L; Millan MJ
    J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Selectively Targeting the α
    Uys MM; Shahid M; Harvey BH
    Front Psychiatry; 2017; 8():144. PubMed ID: 28855875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.